Abstract:Objective:To investigate the effectiveness of surgical treatment for patients with T 4 stage prostate cancer. Methods:The clinical data and prognosis of 18 patients with T 4 stage prostate cancer treated in Shanghai Tenth People's Hospital from July 2013 to December 2019 were retrospectively analyzed. The average age of these 18 patients was 68.3 (53-81)years. 10 patients were castration resistant prostate cancer (CRPC) and 8 patients were hormone-sensitive prostate cancer (HSPC). 10 CRPC patients were treated with surgical treatment due to bladder clot packing and/or lower urinary tract obstruction. 8 HSPC patients had severe hematuria, severe dysuria and local symptoms. The KPS scores of all patients were ≥80 points with an average score of 84 (80-90). The average QOL score of 18 patients was 28 (21-32). 2 cases in 18 patients underwent total pelvic resection for rectal invasion (one CRPC and one HSPC). 7 cases underwent radical cystoprostatectomy for ureteral invasion (5 cases of CRPC, 2 cases of HSPC), 9 cases underwent bladder preservation surgery for bladder neck invasion (4 cases of CRPC, 5 cases of HSPC), of which 4 cases of enlarged lymph node dissection were all HSPC patients. Results:All cases of T 4 stage prostate cancer patients operation were successfully completed, the average operation time was 256 (219-310)min and the median intraoperative blood loss was about 300 (250-350)ml. Four of them (3 cases of CRPC and 1 case of HSPC) received blood transfusion after operation. The average postoperative hospital stay was 21(11-37) days. All 18 cases were followed up and the median follow-up time was 23.8 months. There was no perioperative death, and no bladder-preserving patients had true urinary incontinence or bladder outlet stenosis.2 CRPC cases died 8 and 15 months after surgery respectively, 7 patients were PSA relapse treated with docetaxel or abiterone therapy, and 1 HSPC patient with rectal invasion was followed up for 58 months after total pelvic resection, the PSA level was still 0.003ng/ml, no distant metastasis was found. 8 cases of hormone-sensitive patients were treated with endocrine therapy, and PSA was less than 0.2 ng/ml. The average QOL of 18 patients 3 months after operation was 37 points (25-45), which was significantly higher than that before operation. The average maximum urine flow rate of patients with bladder preservation was 23(19-25)ml/s. Conclusions:For T 4 stage prostate cancer, surgical treatment is feasible and safe for doctors with extensive surgical experience. For CRPC patients, the surgery can significantly improve short-term symptoms and quality of life, and long-term benefits need to be further evaluated with a large sample. For HSPC patients, it can not only improve clinical symptoms and QOL of patients, but also provide long-term benefits.

Transurethral prostate resection for advanced prostate cancer in patients with bladder outlet obstruction

Early Channel Transurethral Resection of the Prostate for Patients with Urinary Retention after Brachytherapy

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Clinical study of channel transurethral resection of the prostate in patients with post-brachytherapy urinary retention (report of 8 cases)

Transurethral Resection of the the Prostate for Lower Urinary Tract Obstruction from Advanced Prostate Cancer

[Efficacy and Outcome of Palliative TURP in Patients with Bladder Outlet Obstruction Induced by Advanced Prostate Cancer].

Transurethral Resection of Prostate Combining Transurethral Cystolithotripsy by Holmium in the Treatment of Bladder Calculi with Benign Prostate Hyperplasia

[Twenty-Eight Cases Report of Transurethral Resection of the Prostate Combined with Repair of Inguinal Hernia].

[TURP plus endocrine therapy (ET) versus α1A-blockers plus ET for bladder outlet obstruction in advanced prostate cancer]

Diagnosis and treatment of advanced prostatic cancer(report of 84 cases)

The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients with Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study

Successful treatment of incidental prostate cancer by radical transurethral resection of prostate cancer

Tamsulosin application for the treatment of advanced prostate cancer accompanied with bladder outlet obstruction

The experience of surgical treatment in T 4 stage prostate cancer

Selective transurethral resection of the prostate combined with transurethral incision of the bladder neck for bladder outlet obstruction in patients with small volume benign prostate hyperplasia (BPH): a prospective randomized study

Transurethral resection of the prostate as emergency surgery for the treatment of BPH with acute urinary retention

Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction

Study on the efficacy and safety of Transurethral enucleation and resection of the prostate in treatment of IV grade Benign prostatic hyperplasia

Radical Transurethral Electrovaporization for the Treatment of Invasive Bladder Cancer

Simultaneous Thulium Laser Resection of the Prostate and Transperineal Prostate Biopsy in Clinically Diagnosed Metastatic Prostate Cancer with Bladder Outlet Obstruction

Analysis of Improved Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate